Drug Approved for Parkinson’s & RLS


The FDA has approved the rotigotine transdermal system (Neupro, UCB) for signs and symptoms of advanced stage idiopathic Parkinson’s disease (PD) and for treating moderate-to-severe primary restless legs syndrome, or RLS. The drug was previously approved for early stage idiopathic PD.

Abstract: UCB.

Submit a Comment

Your email address will not be published. Required fields are marked *

twelve + two =